May 3 |
Blueprint (BPMC) Q1 Earnings and Revenues Beat, Stock Rises
|
May 2 |
Annovis Bio: Alzheimer's Disease Topline Data Disappoints The Market
|
May 2 |
Zoetis (ZTS) Q1 Earnings and Revenues Surpass Estimates
|
May 2 |
Impact Of Buntanetap Trial Results On Annovis Bio Stock And Future Prospects
|
May 2 |
Novo Nordisk (NVO) Q1 Earnings Beat, GLP-1 Drugs Boost Sales
|
May 2 |
Annovis Bio: Alzheimer's Phase 2/3 Topline Readout Puts Future For Buntanetap Into Question
|
Apr 30 |
Annovis Bio: Searching For Efficacy In Alzheimer's Disease
|
Apr 29 |
Why Clever Leaves Holdings Shares Are Trading Lower By Around 60%? Here Are Other Stocks Moving In Monday's Mid-Day Session
|
Apr 29 |
Annovis Bio Shares Tumble After Drug Candidate Buntanetap for Alzheimer's Misses Efficacy Endpoint in Phase 2/3 Study
|
Apr 29 |
Annovis Bio tumbles 53% on data for Alzheimer's candidate buntanetap
|